The End of Cheap Generic Drugs? How a New Court Ruling Could Lock in High Prices
A ruling against skinny labeling could push back generic drug competition by years, with billions in costs passed on to patients and insurers.
Original Source
Read the full article at Inc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.